Sequencing and array-based solutions for genetic research, clinical and applied markets
Discussions related to genomics, sequencing and the applications for sequencing including in rare disease and related reimbursement; S. 2022, Ending the Diagnostic Odyssey Act; H.R. 6000, Cures 2.0 Act; Implementation of American Rescue Plan Act of 2021 (PL 117-2); Continued monitoring of Consolidated Appropriations Act, 2021 (PL 116-260); Ongoing monitoring of CDC surveillance funding; Monitor S. 1260, United States Innovation and Competition Act of 2021 and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 2731, Endless Frontier Act and efforts to bolster US competitiveness against China in critical technology sectors; Monitor H.R. 4521, America COMPETES Act of 2022 and efforts to bolster US competitiveness against China in critical technology sectors; H.R.791/S.236, Tracking COVID-19 Variants Act; H.R. 5376, Build Back Better Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the White House Cancer Moonshot initiative; H.R. 7007, COVID Supplemental Appropriations Act, 2022; S. 3799, PREVENT Pandemics Act; Issues related to the FY 2023 Presidents Budget S.3534/H.R.7152, Tracking Pathogens Act
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
TRACY SPICER JORDAN A LACROSSE